Stock Analysis

Subdued Growth No Barrier To Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. (SZSE:300018) With Shares Advancing 31%

SZSE:300018
Source: Shutterstock

Those holding Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. (SZSE:300018) shares would be relieved that the share price has rebounded 31% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 22% over that time.

Following the firm bounce in price, Wuhan Zhongyuan Huadian Science & TechnologyLtd's price-to-earnings (or "P/E") ratio of 64.7x might make it look like a strong sell right now compared to the market in China, where around half of the companies have P/E ratios below 29x and even P/E's below 18x are quite common. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.

Earnings have risen at a steady rate over the last year for Wuhan Zhongyuan Huadian Science & TechnologyLtd, which is generally not a bad outcome. One possibility is that the P/E is high because investors think this good earnings growth will be enough to outperform the broader market in the near future. If not, then existing shareholders may be a little nervous about the viability of the share price.

See our latest analysis for Wuhan Zhongyuan Huadian Science & TechnologyLtd

pe-multiple-vs-industry
SZSE:300018 Price to Earnings Ratio vs Industry March 7th 2024
We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Wuhan Zhongyuan Huadian Science & TechnologyLtd's earnings, revenue and cash flow.

Is There Enough Growth For Wuhan Zhongyuan Huadian Science & TechnologyLtd?

Wuhan Zhongyuan Huadian Science & TechnologyLtd's P/E ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the market.

Taking a look back first, we see that the company managed to grow earnings per share by a handy 7.1% last year. Ultimately though, it couldn't turn around the poor performance of the prior period, with EPS shrinking 28% in total over the last three years. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.

Comparing that to the market, which is predicted to deliver 41% growth in the next 12 months, the company's downward momentum based on recent medium-term earnings results is a sobering picture.

With this information, we find it concerning that Wuhan Zhongyuan Huadian Science & TechnologyLtd is trading at a P/E higher than the market. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. Only the boldest would assume these prices are sustainable as a continuation of recent earnings trends is likely to weigh heavily on the share price eventually.

The Final Word

Shares in Wuhan Zhongyuan Huadian Science & TechnologyLtd have built up some good momentum lately, which has really inflated its P/E. Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

Our examination of Wuhan Zhongyuan Huadian Science & TechnologyLtd revealed its shrinking earnings over the medium-term aren't impacting its high P/E anywhere near as much as we would have predicted, given the market is set to grow. Right now we are increasingly uncomfortable with the high P/E as this earnings performance is highly unlikely to support such positive sentiment for long. If recent medium-term earnings trends continue, it will place shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

You always need to take note of risks, for example - Wuhan Zhongyuan Huadian Science & TechnologyLtd has 1 warning sign we think you should be aware of.

You might be able to find a better investment than Wuhan Zhongyuan Huadian Science & TechnologyLtd. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Valuation is complex, but we're here to simplify it.

Discover if Wuhan Zhongyuan Huadian Science & TechnologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.